Weekly Policy Update: The FDA’s Initiatives For Medical Devices and the Upcoming Gubernatorial Candidate Forum
By: Colorado BioScience Association Date: 08/24/2018
FDA releases three important initiatives for medical device development, innovation and safety The FDA announced it is taking steps to advance innovation and surveillance for medical devices through t...
Learn MoreWeekly Policy Update: FDA Releases New Draft Guidance and the Midwest BIO CSBA Retreat
By: Colorado BioScience Association Date: 08/17/2018
FDA Releases New Draft Guidance to advance and modernize oncology drug trials In the FDA’s ongoing effort to modernize and create a more efficient approval process, last Friday the FDA released their...
Learn MoreWeekly Policy Update: FDA Funding and Other News
By: Colorado BioScience Association Date: 08/10/2018
FDA Receives Funding in Senate Passed Appropriations Bill Last week the U.S. Senate overwhelmingly passed a $154.2 billion spending bill that includes more than $3 billion for the FDA. When industry f...
Learn MoreWeekly Policy Update: Medical Device Tax and Colorado State Budget
By: Colorado BioScience Association Date: 08/03/2018
Scott Larson, VP, Legal and General Counsel, Terumo BCT; Jenna Hutchins, Territory Manager, ResMed; Congresswoman Dianna Degette; April Giles, President, CBSA; Jonathan Toronto, Vice President,...
Learn MoreWeekly Policy Update: House Repeals Medical Device Tax
By: Colorado BioScience Association Date: 07/27/2018
On behalf of Colorado BioScience Association thank you for your efforts to secure a yes vote on H.R. 184 - Protect Medical Innovation Act of 2017. We appreciate the time you took to advocate to your r...
Learn MoreWeekly Policy Update: Full Repeal of the Medical Device Tax Advocacy
By: Colorado BioScience Association Date: 07/20/2018
This has been another week with persistent advocacy for full repeal of the Medical device tax in standalone legislation. A permanent repeal of the medical device excise tax remains a top priority for...
Learn MoreColorado BioScience Association Announces Departure of President & CEO, April Giles
By: Colorado BioScience Association Date: 07/16/2018
Board of Directors to Begin National Search for Replacement DENVER – Colorado BioScience Association (CBSA) announces the departure of longtime President & CEO April Giles. She served CBSA for mor...
Learn MoreWeekly Policy Update: Medical Device Tax Advocacy and the CACI Legislative Candidate Interviews
By: Colorado BioScience Association Date: 07/13/2018
CBSA continues to advocate for a full repeal of the Medical device tax in standalone legislation. A permanent repeal of the tax remains a top priority for CBSA and Colorado's medtech innovators. While...
Learn MoreWeekly Policy Update: Meeting with Congresswoman Degette
By: Colorado BioScience Association Date: 07/06/2018
This week Colorado BioScience Association along with AdvaMed, our Board Chair Scott Larson at Terumo BCT, Zimmer Biomet and ResMed met with Congresswoman DeGette. The meeting offered a great opportuni...
Learn MoreWeekly Policy Update: Primary Elections, Congratulating Sen. Gardner, and Drug Pricing
By: Colorado BioScience Association Date: 06/28/2018
2018 COLORADO PRIMARY ELECTION With the anticipated Colorado Primary Election this week, we learned the long-awaited results of who would be our top two democratic and republican candidates for Govern...
Learn More